News

An epidemic of chronic diseases continues to grow in the United States; half the population — an estimated 129 million Americans — have lifelong health conditions that need continuous medical attention and limit certain daily activities.

Asthma, a chronic condition that affects the airways in the lungs, can lead to a range of symptoms that interfere with daily life. While most people are familiar with the most common symptoms of asthma such as wheezing or whistling sounds, shortness of breath, chest tightness and frequent coughing, several others are not as widely recognized.

Like clockwork, two times a year — cold and flu season and allergy season — we get a tingle in our sinuses that can only mean one thing: The snot floodgates are about to open.

What is the difference between cardiovascular disease and heart disease?

These two terms are often used interchangeably, but there is a difference. Cardiovascular disease is an umbrella term that encompasses several heart conditions, including heart disease, coronary heart disease, stroke, heart failure and peripheral artery disease.

For neurologists working with patients with Alzheimer’s disease, the road to actual treatment options has been long and paved with setbacks.

But that is changing for some patients. The Food and Drug Administration recently granted full approval to Leqembi® (lecanemab), the first disease-modifying treatment fully approved for patients in the early stages of Alzheimer’s disease. The development of this new drug offers hope to patients and may have lasting impacts on how physicians approach treatment.